Table 2. Mean length SDS for 0–1 year old end-stage renal disease patients.
| Country | Mean length SDS (SE) | |||||
| N | National1 | Recent National/European | WHO | Euro-Growth2 | ||
| Belgium | 2 | −2.62 (1.64) | −2.62 (1.64) | −3.07 (1.19) | −2.62 (1.59) | |
| Czech Republic | 3 | −1.80 (0.70) | −1.80 (0.70) | −1.91 (0.91) | −1.99 (0.85) | |
| Finland | 7 | −1.39 (0.46) | −1.33 (0.47) | −1.24 (0.50) | −1.26 (0.49) | |
| France | 20 | −1.91 (0.42) | −2.12 (0.36) | −2.56 (0.43) | −2.46 (0.41) | |
| Lithuania | 2 | −1.00 (0.26) | −1.00 (0.26) | −1.07 (0.36) | −1.11 (0.36) | |
| Norway | 1 | −0.90 | −0.90 | −0.83 | −1.03 | |
| Romania | 1 | 1.97 | 1.16 | 1.25 | 1.08 | |
| Russia | 4 | −2.50 (1.15) | −3.23 (1.13) | −3.22 (1.26) | −3.27 (1.22) | |
| Spain | 22 | −1.72 (0.33) | −1.72 (0.33) | −1.99 (0.35) | −1.99 (0.38) | |
| Switzerland | 3 | −0.89 (0.86) | −0.75 (0.85) | −1.09 (0.61) | −0.86 (0.76) | |
| United Kingdom | 21 | −3.13 (0.37) | −2.83 (0.28) | −2.84 (0.30) | −2.87 (0.30) | |
| All countries3 | 86 | −2.04 (0.19) | −2.05 (0.17) | −2.24 (0.19) | −2.22 (0.19) | |
1
National growth charts refer to both growth charts based on data collected before 1990 as well as to recent national growth charts;
2
As the CDC recommends the use of the WHO growth standards for children under the age of 2 years, mean length SDS values based on the CDC for children younger than 2 years are not reported;
3
These values represent the average length SDS of children with ESRD from all European countries together.